<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>919</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>10432283</PubmedId>
            <Abstract>Major histocompatibility complex (MHC) class Ib molecules have been implicated in CD8(+) T cell-mediated defenses against intracellular bacterial infection, but the relative importance of MHC class Ib-restricted T cells in antimicrobial immunity is unknown. In this report, we use MHC tetramers to characterize T cell responses restricted by H2-M3, an MHC class Ib molecule that selectively presents N-formyl peptides. We find that sizeable H2-M3-restricted T cell responses, occurring earlier than MHC class Ia-restricted T cell responses, are mounted after primary infection with the intracellular bacterium Listeria monocytogenes. These H2-M3-restricted T cells are cytolytic and produce interferon gamma. However, after a second L. monocytogenes infection, H2-M3-restricted memory T cell responses are minor in comparison to the much larger MHC class Ia-restricted responses. This first direct characterization of an MHC class Ib-restricted T cell response indicates that CD8(+) T cells responding to L. monocytogenes infection can be divided into two groups: H2-M3-restricted responses, which provide rapid and quantitatively substantial effector function during primary infections but contribute relatively little to memory responses, and MHC class Ia-restricted responses, which expand later during primary infection but form memory T cells that respond rapidly and dramatically in response to subsequent infections by the same pathogen.</Abstract>
            <ArticleYear>1999</ArticleYear>
            <ArticlePages>195-204</ArticlePages>
            <ArticleTitle>H2-M3-restricted T cells in bacterial infection: rapid primary but diminished memory responses.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Kerksiek</LastName>
                    <ForeName>K M</ForeName>
                </Author>
                <Author>
                    <LastName>Busch</LastName>
                    <ForeName>D H</ForeName>
                </Author>
                <Author>
                    <LastName>Pilip</LastName>
                    <ForeName>I M</ForeName>
                </Author>
                <Author>
                    <LastName>Allen</LastName>
                    <ForeName>S E</ForeName>
                </Author>
                <Author>
                    <LastName>Pamer</LastName>
                    <ForeName>E G</ForeName>
                </Author>
            </Authors>
            <Affiliations>Section of Infectious Diseases and Section of Immunobiology, Yale University School of Medicine, New Haven, Connecticut 06520, USA.</Affiliations>
            <ArticleChemicalList>Antigens, Bacterial;DNA Primers;Epitopes;Histocompatibility Antigens Class II</ArticleChemicalList>
            <ArticleMeshHeadingsList>Animals; Antigens, Bacterial(chemistry); Base Sequence; CD8-Positive T-Lymphocytes(immunology); DNA Primers(genetics); Epitopes(chemistry); Female; Histocompatibility Antigens Class II(chemistry; genetics); Immunologic Memory; In Vitro Techniques; Listeria monocytogenes(immunology); Listeriosis(immunology); Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Protein Conformation</ArticleMeshHeadingsList>
            <Journal>
                <Volume>190</Volume>
                <Issue>2</Issue>
                <Title>The Journal of experimental medicine</Title>
                <Issn>0022-1007</Issn>
                <MedlineTa>J Exp Med</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>f-MIGWIIA</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MIGWIIA</LinearSequence>
                        <ModifiedResidues>M1</ModifiedResidues>
                        <Modifications>Formylation|FORM</Modifications>
                        <StartingPosition>1</StartingPosition>
                        <EndingPosition>7</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>Q8Y8E2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1639</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>P. 196</LocationOfData>
                <EpitopeId>41711</EpitopeId>
                <ReferenceStartingPosition>1</ReferenceStartingPosition>
                <ReferenceEndingPosition>7</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3A</LocationOfData>
                        <TCellId>10491</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>1639</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Listeria monocytogenes</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Other</Route>
                                <DoseSchedule>1x tail vein injection.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <MhcAllele>
                            <MhcAlleleId>128</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Single MHC type present</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>f-MIGWIIA</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MIGWIIA</LinearSequence>
                                        <ModifiedResidues>M1</ModifiedResidues>
                                        <Modifications>Formylation|FORM</Modifications>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>7</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>Q8Y8E2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1639</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>47</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>When splenocytes were sampled at 5, 7 and 9 days after infection, the maximum response was observed at 7 days post-infection. It should be noted that the population of H2-M3/f-MIGWIIA tetramer-staining CD8+ T cells from  BABL/c mice was much smaller than the corresponding populations from C57BL/6 and C3H/HeJ mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>10495</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000216</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>1639</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Listeria monocytogenes</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Other</Route>
                                <DoseSchedule>1x tail vein injection.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Other</CellTissueType>
                            <CellType>P815-Mast cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <SourceOrganismId>10090</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>128</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Single MHC type present</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>f-MIGWIIA</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MIGWIIA</LinearSequence>
                                        <ModifiedResidues>M1</ModifiedResidues>
                                        <Modifications>Formylation|FORM</Modifications>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>7</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>Q8Y8E2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1639</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>All f-MIGWIIA-specific T cells were detected with the tetramers. The IFN-γ production and CTL activity of these H2-M3-restricted T cells was present early (day 5) after primary infection, demonstrating that they are functional CD8+ T cells.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3A</LocationOfData>
                        <TCellId>10486</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>1639</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Listeria monocytogenes</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Other</Route>
                                <DoseSchedule>1x tail vein injection.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <MhcAllele>
                            <MhcAlleleId>128</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Single MHC type present</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>f-MIGWIIA</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MIGWIIA</LinearSequence>
                                        <ModifiedResidues>M1</ModifiedResidues>
                                        <Modifications>Formylation|FORM</Modifications>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>7</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>Q8Y8E2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1639</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>47</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>When splenocytes were sampled at 5, 7 and 9 days after infection, the maximum response was observed at 7 days post-infection.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>10498</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000216</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>1639</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Listeria monocytogenes</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Other</Route>
                                <DoseSchedule>1x tail vein injection.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Other</CellTissueType>
                            <CellType>P815-Mast cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <SourceOrganismId>10090</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>128</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Single MHC type present</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>f-MIGWIIA</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MIGWIIA</LinearSequence>
                                        <ModifiedResidues>M1</ModifiedResidues>
                                        <Modifications>Formylation|FORM</Modifications>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>7</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>Q8Y8E2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1639</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The IFN-γ production and CTL activity of these H2-M3-restricted T cells was present early (day 5) after primary infection, demonstrating that they are functional CD8+ T cells.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3A</LocationOfData>
                        <TCellId>10489</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000038</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>1639</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Listeria monocytogenes</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Other</Route>
                                <DoseSchedule>1x tail vein injection.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <MhcAllele>
                            <MhcAlleleId>128</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Single MHC type present</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>f-MIGWIIA</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MIGWIIA</LinearSequence>
                                        <ModifiedResidues>M1</ModifiedResidues>
                                        <Modifications>Formylation|FORM</Modifications>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>7</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>Q8Y8E2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1639</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>47</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>When splenocytes were sampled at 5, 7 and 9 days after infection, the maximum response was observed at 7 days post-infection.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>10493</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000216</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>1639</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Listeria monocytogenes</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Other</Route>
                                <DoseSchedule>1x tail vein injection.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <MhcAllele>
                            <MhcAlleleId>128</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Single MHC type present</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>f-MIGWIIA</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MIGWIIA</LinearSequence>
                                        <ModifiedResidues>M1</ModifiedResidues>
                                        <Modifications>Formylation|FORM</Modifications>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>7</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>Q8Y8E2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1639</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>47</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The H2-M3-restricted T cell responses peaked earlier than H2-Kd-restricted responses during primary L. monocytogenes infection. When mice were reinfected with L. monocytogene at 48 d after the primary infection, H2-M3-restricted T cells underwent little expansion duirng the secondary L. monocytogenes infection as compared with H2-Kd-restricted T cells.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

